1 - 25 of
202
results
for author:"Klein C."
in Literature Citations
| ATP13A2 variants in early-onset Parkinson's disease patients and controls. Djarmati A., Hagenah J., Reetz K., Winkler S., Behrens M.I., Pawlack H., Lohmann K., Ramirez A., Tadic V., Bruggemann N. et al. Mov. Disord. 24:2104-2111(2009) · Mapped (6) |
| A genome-wide screen in Saccharomyces cerevisiae reveals pathways affected by arsenic toxicity. Zhou X., Arita A., Ellen T.P., Liu X., Bai J., Rooney J.P., Kurtz A.D., Klein C.B., Dai W., Begley T.J. et al. Genomics 94:294-307(2009) · Mapped (12) |
| Autocrine regulation of early embryonic development by the artemin-GFRA3 (GDNF family receptor-alpha 3) signaling system in mice. Li J., Klein C., Liang C., Rauch R., Kawamura K., Hsueh A.J. FEBS Lett. 583:2479-2485(2009) · Mapped (5) |
| Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology. Grunewald A., Gegg M.E., Taanman J.W., King R.H., Kock N., Klein C., Schapira A.H. Exp. Neurol. 219:266-273(2009) · Mapped (1) |
| Xenopus laevis oocytes endogenously express all subunits of the ionotropic glutamate receptor family. Schmidt C., Klein C., Hollmann M. J. Mol. Biol. 390:182-195(2009) · UniProtKB (18) |
| The D216H variant in the DYT1 gene: a susceptibility factor for dystonia in familial cases? Bruggemann N., Kock N., Lohmann K., Konig I.R., Rakovic A., Hagenah J., Schmidt A., Ziegler A., Jabusch H.C., Siebner H. et al. Neurology 72:1441-1443(2009) · Mapped (3) |
| MAPKAP kinase MK2 maintains self-renewal capacity of haematopoietic stem cells. Schwermann J., Rathinam C., Schubert M., Schumacher S., Noyan F., Koseki H., Kotlyarov A., Klein C., Gaestel M. EMBO J. 28:1392-1406(2009) · Mapped (2) |
| Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism. Paus S., Gadow F., Knapp M., Klein C., Klockgether T., Wullner U. Mov. Disord. 24:1080-1084(2009) · Mapped (6) |
| Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study. Djarmati A., Schneider S.A., Lohmann K., Winkler S., Pawlack H., Hagenah J., Bruggemann N., Zittel S., Fuchs T., Rakovic A. et al. Lancet Neurol 8:447-452(2009) · Mapped (1) |
| c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Giebeler A., Boekschoten M.V., Klein C., Borowiak M., Birchmeier C., Gassler N., Wasmuth H.E., Muller M., Trautwein C., Streetz K.L. Gastroenterology 137:297-308, 2009:308.e1-4(2009) · Mapped (9) |
| SEPT9 mutations and a conserved 17q25 sequence in sporadic and hereditary brachial plexus neuropathy. Klein C.J., Wu Y., Cunningham J.M., Windebank A.J., Dyck P.J., Friedenberg S.M., Klein D.M., Dyck P.J. Arch. Neurol. 66:238-243(2009) · Mapped (5) |
| MDR1 variants and risk of Parkinson disease. Association with pesticide exposure? Zschiedrich K., Konig I.R., Bruggemann N., Kock N., Kasten M., Leenders K.L., Kostic V., Vieregge P., Ziegler A., Klein C. et al. J. Neurol. 256:115-120(2009) · Mapped (8) |
| Frequency of heterozygous Parkin mutations in healthy subjects: need for careful prospective follow-up examination of mutation carriers. Bruggemann N., Mitterer M., Lanthaler A.J., Djarmati A., Hagenah J., Wiegers K., Winkler S., Pawlack H., Lohnau T., Pramstaller P.P. et al. Parkinsonism Relat. Disord. 15:425-429(2009) · Mapped (14) |
| On the abundance of EpCAM on cancer stem cells. Gires O., Klein C.A., Baeuerle P.A. Nat. Rev. Cancer 9:143; author reply 2009:143-143(2009) · Mapped (1) |
| A syndrome with congenital neutropenia and mutations in G6PC3. Boztug K., Appaswamy G., Ashikov A., Schaeffer A.A., Salzer U., Diestelhorst J., Germeshausen M., Brandes G., Lee-Gossler J., Noyan F. et al. N. Engl. J. Med. 360:32-43(2009) · UniProtKB (1) |
| Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease. Rakovic A., Stiller B., Djarmati A., Flaquer A., Freudenberg J., Toliat M.R., Linnebank M., Kostic V., Lohmann K., Paus S. et al. Mov. Disord. 24:429-433(2009) · Mapped (6) |
| Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype. van Nuenen B.F., Weiss M.M., Bloem B.R., Reetz K., van Eimeren T., Lohmann K., Hagenah J., Pramstaller P.P., Binkofski F., Klein C. et al. Neurology 72:1041-1047(2009) · Mapped (15) |
| The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. Latourelle J.C., Sun M., Lew M.F., Suchowersky O., Klein C., Golbe L.I., Mark M.H., Growdon J.H., Wooten G.F., Watts R.L. et al. BMC Med 6:32-32(2008) · Mapped (4) |
| Transcription factor Gfi1 restricts B cell-mediated autoimmunity. Rathinam C., Lassmann H., Mengel M., Klein C. J. Immunol. 181:6222-6229(2008) · Mapped (5) |
| Myoclonus-dystonia due to maternal uniparental disomy. Guettard E., Portnoi M.F., Lohmann-Hedrich K., Keren B., Rossignol S., Winkler S., El Kamel I., Leu S., Apartis E., Vidailhet M. et al. Arch. Neurol. 65:1380-1385(2008) · Mapped (4) |
| Neuronostatin encoded by the somatostatin gene regulates neuronal, cardiovascular, and metabolic functions. Samson W.K., Zhang J.V., Avsian-Kretchmer O., Cui K., Yosten G.L., Klein C., Lyu R.M., Wang Y.X., Chen X.Q., Yang J. et al. J. Biol. Chem. 283:31949-31959(2008) · Mapped (1) |
| Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. McNicoll C.F., Latourelle J.C., MacDonald M.E., Lew M.F., Suchowersky O., Klein C., Golbe L.I., Mark M.H., Growdon J.H., Wooten G.F. et al. Mov. Disord. 23:1596-1601(2008) · Mapped (3) |
| Replication of association between ELAVL4 and Parkinson disease: the GenePD study. DeStefano A.L., Latourelle J., Lew M.F., Suchowersky O., Klein C., Golbe L.I., Mark M.H., Growdon J.H., Wooten G.F., Watts R. et al. Hum. Genet. 124:95-99(2008) · Mapped (6) |
| Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9. Sienel W., Polzer B., Elshawi K., Lindner M., Morresi-Hauf A., Vay C., Eder F., Passlick B., Klein C.A. Mod. Pathol. 21:1130-1138(2008) · Mapped (6) |
| Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. International LRRK2 Consortium Lancet Neurol 7:583-590(2008) · Mapped (4) |
